Challenging the management of drug-resistant tuberculosis

Lancet. 2020 Mar 7;395(10226):783. doi: 10.1016/S0140-6736(20)30049-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents
  • Humans
  • Tuberculosis, Multidrug-Resistant*

Substances

  • Antitubercular Agents